Selected research
Industry Research
Neonatal Genetic Disease Diagnosis Industry Research Report 2026
Market perspective
The global Neonatal Genetic Disease Diagnosis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Neonatal Genetic Disease Diagnosis market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Neonatal Genetic Disease Diagnosis market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Neonatal Genetic Disease Diagnosis market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Neonatal Genetic Disease Diagnosis include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd. and Illumina and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Neonatal Genetic Disease Diagnosis market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Neonatal Genetic Disease Diagnosis.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neonatal Genetic Disease Diagnosis Market by Company
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology
Neonatal Genetic Disease Diagnosis Segment by Type
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others
Neonatal Genetic Disease Diagnosis Segment by Application
Hospital
Medical Laboratory
Others
Neonatal Genetic Disease Diagnosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neonatal Genetic Disease Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neonatal Genetic Disease Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neonatal Genetic Disease Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Neonatal Genetic Disease Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prenatal Diagnosis
- Screening for Single Gene Genetic Disease
- Preimplantation Genetic Testing
- Others
Applications
- Hospital
- Medical Laboratory
- Others
Companies covered
- Abbott
- PerkinElmer
- Roche Diagnostics
- Bio Rad
- Thermo Fisher Scientific
- BGI Group
- Berry Genomics
- Da An Gene Co., Ltd.
- Illumina
- CapitalBio Technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Neonatal Genetic Disease Diagnosis by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Prenatal Diagnosis
- 2.2.3 Screening for Single Gene Genetic Disease
- 2.2.4 Preimplantation Genetic Testing
- 2.2.5 Others
- 2.3 Neonatal Genetic Disease Diagnosis by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Medical Laboratory
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Neonatal Genetic Disease Diagnosis Breakdown Data by Type
- 3.1 Global Neonatal Genetic Disease Diagnosis Historic Market Size by Type (2021-2026)
- 3.2 Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Type (2027-2032)
4 Neonatal Genetic Disease Diagnosis Breakdown Data by Application
- 4.1 Global Neonatal Genetic Disease Diagnosis Historic Market Size by Application (2021-2026)
- 4.2 Global Neonatal Genetic Disease Diagnosis Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Neonatal Genetic Disease Diagnosis Market Perspective (2021-2032)
- 5.2 Global Neonatal Genetic Disease Diagnosis Growth Trends by Region
- 5.2.1 Global Neonatal Genetic Disease Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Neonatal Genetic Disease Diagnosis Historic Market Size by Region (2021-2026)
- 5.2.3 Neonatal Genetic Disease Diagnosis Forecasted Market Size by Region (2027-2032)
- 5.3 Neonatal Genetic Disease Diagnosis Market Dynamics
- 5.3.1 Neonatal Genetic Disease Diagnosis Industry Trends
- 5.3.2 Neonatal Genetic Disease Diagnosis Market Drivers
- 5.3.3 Neonatal Genetic Disease Diagnosis Market Challenges
- 5.3.4 Neonatal Genetic Disease Diagnosis Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Neonatal Genetic Disease Diagnosis Players by Revenue
- 6.1.1 Global Top Neonatal Genetic Disease Diagnosis Players by Revenue (2021-2026)
- 6.1.2 Global Neonatal Genetic Disease Diagnosis Revenue Market Share by Players (2021-2026)
- 6.2 Global Neonatal Genetic Disease Diagnosis Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Neonatal Genetic Disease Diagnosis Head Office and Area Served
- 6.4 Global Neonatal Genetic Disease Diagnosis Players, Product Type & Application
- 6.5 Global Neonatal Genetic Disease Diagnosis Manufacturers Established Date
- 6.6 Global Neonatal Genetic Disease Diagnosis Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Neonatal Genetic Disease Diagnosis Market Size (2021-2032)
- 7.2 North America Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Neonatal Genetic Disease Diagnosis Market Size by Country (2021-2026)
- 7.4 North America Neonatal Genetic Disease Diagnosis Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Neonatal Genetic Disease Diagnosis Market Size (2021-2032)
- 8.2 Europe Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2021-2026)
- 8.4 Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size (2021-2032)
- 9.2 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Neonatal Genetic Disease Diagnosis Market Size (2021-2032)
- 10.2 South America Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Neonatal Genetic Disease Diagnosis Market Size by Country (2021-2026)
- 10.4 South America Neonatal Genetic Disease Diagnosis Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size (2021-2032)
- 11.2 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbott
- 12.1.1 Abbott Company Information
- 12.1.2 Abbott Business Overview
- 12.1.3 Abbott Revenue in Neonatal Genetic Disease Diagnosis Business (2021-2026)
- 12.1.4 Abbott Neonatal Genetic Disease Diagnosis Product Portfolio
- 12.1.5 Abbott Recent Developments
- 12.2 PerkinElmer
- 12.2.1 PerkinElmer Company Information
- 12.2.2 PerkinElmer Business Overview
- 12.2.3 PerkinElmer Revenue in Neonatal Genetic Disease Diagnosis Business (2021-2026)
- 12.2.4 PerkinElmer Neonatal Genetic Disease Diagnosis Product Portfolio
- 12.2.5 PerkinElmer Recent Developments
- 12.3 Roche Diagnostics
- 12.3.1 Roche Diagnostics Company Information
- 12.3.2 Roche Diagnostics Business Overview
- 12.3.3 Roche Diagnostics Revenue in Neonatal Genetic Disease Diagnosis Business (2021-2026)
- 12.3.4 Roche Diagnostics Neonatal Genetic Disease Diagnosis Product Portfolio
- 12.3.5 Roche Diagnostics Recent Developments
- 12.4 Bio Rad
- 12.4.1 Bio Rad Company Information
- 12.4.2 Bio Rad Business Overview
- 12.4.3 Bio Rad Revenue in Neonatal Genetic Disease Diagnosis Business (2021-2026)
- 12.4.4 Bio Rad Neonatal Genetic Disease Diagnosis Product Portfolio
- 12.4.5 Bio Rad Recent Developments
- 12.5 Thermo Fisher Scientific
- 12.5.1 Thermo Fisher Scientific Company Information
- 12.5.2 Thermo Fisher Scientific Business Overview
- 12.5.3 Thermo Fisher Scientific Revenue in Neonatal Genetic Disease Diagnosis Business (2021-2026)
- 12.5.4 Thermo Fisher Scientific Neonatal Genetic Disease Diagnosis Product Portfolio
- 12.5.5 Thermo Fisher Scientific Recent Developments
- 12.6 BGI Group
- 12.6.1 BGI Group Company Information
- 12.6.2 BGI Group Business Overview
- 12.6.3 BGI Group Revenue in Neonatal Genetic Disease Diagnosis Business (2021-2026)
- 12.6.4 BGI Group Neonatal Genetic Disease Diagnosis Product Portfolio
- 12.6.5 BGI Group Recent Developments
- 12.7 Berry Genomics
- 12.7.1 Berry Genomics Company Information
- 12.7.2 Berry Genomics Business Overview
- 12.7.3 Berry Genomics Revenue in Neonatal Genetic Disease Diagnosis Business (2021-2026)
- 12.7.4 Berry Genomics Neonatal Genetic Disease Diagnosis Product Portfolio
- 12.7.5 Berry Genomics Recent Developments
- 12.8 Da An Gene Co., Ltd.
- 12.8.1 Da An Gene Co., Ltd. Company Information
- 12.8.2 Da An Gene Co., Ltd. Business Overview
- 12.8.3 Da An Gene Co., Ltd. Revenue in Neonatal Genetic Disease Diagnosis Business (2021-2026)
- 12.8.4 Da An Gene Co., Ltd. Neonatal Genetic Disease Diagnosis Product Portfolio
- 12.8.5 Da An Gene Co., Ltd. Recent Developments
- 12.9 Illumina
- 12.9.1 Illumina Company Information
- 12.9.2 Illumina Business Overview
- 12.9.3 Illumina Revenue in Neonatal Genetic Disease Diagnosis Business (2021-2026)
- 12.9.4 Illumina Neonatal Genetic Disease Diagnosis Product Portfolio
- 12.9.5 Illumina Recent Developments
- 12.10 CapitalBio Technology
- 12.10.1 CapitalBio Technology Company Information
- 12.10.2 CapitalBio Technology Business Overview
- 12.10.3 CapitalBio Technology Revenue in Neonatal Genetic Disease Diagnosis Business (2021-2026)
- 12.10.4 CapitalBio Technology Neonatal Genetic Disease Diagnosis Product Portfolio
- 12.10.5 CapitalBio Technology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst